Latest News

Isis start-up Oxford BioChronometrics featured in Guardian

18th July 2014

All News | Spinouts & Startups | Startup Incubator | Technology News

Oxford BioChronometrics was featured in a story in the Guardian “How your electronic DNA could be the secure login of the future."

Brainomix makes awards shortlist

3rd July 2014

All News | Spinouts & Startups

Brainomix Ltd, a start-up from the Isis Software Incubator has been announced as a finalist in the ICT category of the Academic Enterprise Awards 2014.

Silicon Spires meets Silicon Roundabout

3rd June 2014

All News | Spinouts & Startups

The Isis Software Incubator, part of Oxford University Innovation, the University of Oxford’s technology commercialisation company, and City University London, have announced a new partnership.

Isis spin-out Oxford BioMedica raises £20m

2nd June 2014

All News | Spinouts & Startups

Gene therapy specialist Oxford Biomedica has raised £20m to fund its portfolio of ophthalmology, CNS and cancer treatments.

Oxford Immunotec receives 2014 Queen’s Award for Enterprise

23rd April 2014

All News | Spinouts & Startups

Oxford University Innovation spin-out Oxford Immunotec has received a 2014 Queen’s Award for Enterprise.

Isis spin-out Organox closes series D round

16th April 2014

All News | Spinouts & Startups

OrganOx, a late-stage medical device company focused on increasing the quality and supply of organs for transplantation, has announced that it has closed a Series D Investment round.

Isis spin-out aims to 3D print synthetic tissues, organs

16th April 2014

All News | Spinouts & Startups | Technology News

A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery.

Oxford University Innovation spin-out to manufacture designer spherical nanomaterials

14th April 2014

All News | Spinouts & Startups | Technology News

Next generation carbon nanomaterials such as graphene, carbon nanotubes and fullerenes, with their unique physical properties, have been hailed as “miracle materials”.

Immunocore shows promise in treating melanoma

9th April 2014

All News | Spinouts & Startups

Oxford-based Immunocore has announced that its immune therapy has shown promising early signs of efficacy in a Phase I trial in advanced melanoma patients.

New Drugs to Treat Duchenne Muscular Dystrophy

9th April 2014

All News | Spinouts & Startups | Technology News

Reviving a gene which is “turned down” after birth is potentially the key to treating Duchenne Muscular Dystrophy, an untreatable muscle-wasting condition which affects one in every 3,500 boys.

News

Ready to get in touch?